Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2021
Reporting Period: As of July 15, 2021
Business Context: The filing discloses the release of investor presentation materials intended for publication on the company's website. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol PCSA.
Key Financial Metrics
This Form 8-K is a disclosure of non-financial presentation materials and does not contain audited or unaudited financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document serves solely to notify the SEC of the release of the "Processa Pharmaceuticals Investor Presentation dated July 2021" (Exhibit 99.1).
Guidance, Outlook, and Risks
- Management Commentary: The company intends to publish the attached slide presentation to its website. The presentation speaks as of the date of this report.
- Forward-Looking Statements: Processa Pharmaceuticals specifically disclaims any obligation to update the presentation materials in the future or to reflect events occurring after the date of this report.
- Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the attached "Processa Pharmaceuticals Investor Presentation dated July 2021" (Exhibit 99.1) for specific operational updates or strategic shifts.
- Confirm that the presentation materials are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.
- Review subsequent filings (e.g., 10-Q or 10-K) for actual financial metrics, as this 8-K contains no numerical financial data.
- Monitor the company website for any voluntary updates to the presentation, noting that the company has disclaimed an obligation to do so.